The Spine Biologics Market Size is projected to grow from USD 2.9 Billion in 2023 to USD 4.3 Billion by 2032, exhibiting a CAGR of 4.90% during the forecast period (2023 - 2032).  The Spine Biologics market is witnessing significant growth as innovative technologies and advanced treatments continue to reshape the landscape of spinal care. Spine biologics refer to substances that...